BioVie Inc. Class A BIVI
NASDAQ · United States · Health Technology
$1.46-0.01 (-0.68%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q1 2026 | 2025-11-10 | -0.98 | -0.79 | -24.1% | +2.0%$1.48→$1.51 |
| Q4 2025 | 2025-08-15 | -11.05 | -3.60 | -206.9% | — |
| Q3 2025 | 2025-05-12 | -1.50 | -3.20 | +53.1% | — |
| Q2 2025 | 2025-02-11 | -4.60 | -16.00 | +71.3% | — |
| Q3 2024 | 2024-05-14 | -20.00 | -25.00 | +20.0% | — |
| Q2 2024 | 2024-02-13 | -22.00 | -27.50 | +20.0% | — |
| Q1 2024 | 2023-11-08 | -29.00 | -31.00 | +6.5% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.